Loading clinical trials...
Loading clinical trials...
Assesment of JL1 Expression in B-cell Acute Lymphoblastic Leukemia
Conditions
Interventions
JL1 antigen
Start Date
October 13, 2020
Primary Completion Date
October 1, 2023
Completion Date
November 1, 2023
Last Updated
September 18, 2020
NCT05376111
NCT04065399
NCT05453500
NCT07295951
NCT05292664
NCT03970096
Lead Sponsor
Assiut University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions